You are here

  • Home
  • Archive
  • Volume 78, Issue 10
  • Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer’s disease from dementia with Lewy bodies

Article info

Article menu
Download PDFPDF
Paper
Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer’s disease from dementia with Lewy bodies

Authors

  1. Dr John-Paul Taylor, Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK; john-paul.taylor{at}ncl.ac.uk
View Full Text

Citation

Taylor J, Colloby SJ, McKeith IG, et al
Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer’s disease from dementia with Lewy bodies
Journal of Neurology, Neurosurgery & Psychiatry 2007;78:1069-1071.

Publication history

  • Received November 21, 2006
  • Accepted January 26, 2007
  • Final version accepted February 5, 2007
  • First published February 13, 2007.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2007 BMJ Publishing Group